Martek Can't Duck Baby Formula Ingredients Antitrust Suit

Law360, New York (December 14, 2011, 7:07 PM EST) -- A Maryland federal judge on Wednesday denied Martek Biosciences Corp.’s bid to toss an antitrust suit by Belgian additive maker BNLfood Investment SARL alleging the nutritional products developer uses long-term contracts to dominate the U.S. market for enriched ingredients for infant formulas.

U.S. District Judge William D. Quarles Jr. ruled that BNLfood had adequately established its antitrust standing in accusing Martek of conducting monopolistic practices in violation of the Sherman Act by reducing its competition in the U.S., as well as in violation of the Clayton...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.